Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Mark Crossley"


3 mentions found


Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailIndivior CEO Mark Crossley on combatting the opioid crisis with new drugsMark Crossley, Indivior CEO, joins 'Squawk Box' to discuss what Indivior does, how much the company's drugs costs, and usage of the company's drugs.
Persons: Mark Crossley Organizations: Indivior
Aug 21 (Reuters) - Indivior (INDV.L) has agreed to pay $30 million to settle a class action lawsuit filed in a U.S. court by health plans accusing the drugmaker of illegally suppressing generic competition for its opioid addiction treatment Suboxone. The settlement, disclosed on Saturday in a filing by lawyers for the health plans in federal court in Philadelphia, must still be approved by a judge. Indivior is still facing claims by drug wholesalers that bought Suboxone from the Virginia-based company directly, with a trial scheduled in October. Lawyers for the health plans did not immediately respond to requests for comment. Indivior agreed in June to pay $102.5 million to settle related claims by 41 U.S. states and Washington, D.C.
Persons: Indivior, Mark Crossley, Suboxone, Brendan Pierson, Will Dunham, Alexia Garamfalvi Organizations: U.S, D.C, U.S . Centers for Disease Control, Thomson Locations: U.S, Philadelphia, Virginia, Washington, United States, New York
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailIndivior CEO Mark Crossley on company mission: We help people suffering from addictionIndivior CEO Mark Crossley joins 'Squawk Box' to discuss the company's mission, demand for substance abuse treatment, the opioid epidemic, and more.
Persons: Mark Crossley
Total: 3